Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma

SIMPLE SUMMARY: Immunotherapy leads to durable responses in a proportion of patients with advanced melanoma. Combination immunotherapy is more efficacious than single-agent immunotherapy, yet it is associated with significant toxicity. Currently there are no robust biomarkers to guide first-line imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shklovskaya, Elena, Lee, Jenny H, Lim, Su Yin, Stewart, Ashleigh, Pedersen, Bernadette, Ferguson, Peter, Saw, Robyn PM, Thompson, John F, Shivalingam, Brindha, Carlino, Matteo S, Scolyer, Richard A, Menzies, Alexander M, Long, Georgina V, Kefford, Richard F, Rizos, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696726/
https://www.ncbi.nlm.nih.gov/pubmed/33202676
http://dx.doi.org/10.3390/cancers12113374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696726/
https://www.ncbi.nlm.nih.gov/pubmed/33202676
http://dx.doi.org/10.3390/cancers12113374

Ejemplares similares